ERS International Congress, Milan 2017

---

CAP: severity scores, risk groups and biomarkers

Thematic Poster
Chairs: A. Liapikou (Athens, Greece), O. Sibila Vidal (Barcelona, Spain), R. Menendez Villanueva (Valencia, Spain), M. van der Eerden (Rotterdam, Netherlands)

ONE YEAR MORTALITY IN PATIENTS WITH PNEUMOCOCCAL BACTERAEMIC COMMUNITY ACQUIRED PNEUMONIA: ROLE OF THREE PNEUMONIA SEVERITY SCORES L. Serrano Fernandez (Bilbao (Bizkaia), Spain)
Comparison of pneumonia severity scoring methods in identification of severe community acquired pneumonia R. Lee (London, United Kingdom)
Is the CURB65 score fit for purpose - a retrospective analysis D. Dosanjh (London, United Kingdom)
The comparisons of severity scoring systems for community acquired pneumonia patients with chronic obstructive pulmonary disease J. Xu (Shanghai, China)
DIFFERENCES IN COMMUNITY ACQUIRED PNEUMONIA ACCORDING TO GENDER B. Gonzalez Quero (bilbao, Spain)
Predictive factors for multidrug-resistant pathogens in hemodialysis patients with pneumonia : a multicenter study H. Lee (Jeju, Republic of Korea)
The glycemic gap and 90-day mortality in community-acquired pneumonia- A prospective cohort study A. Jensen (Roskilde, Denmark)
Undiagnosed diabetes mellitus in community-acquired pneumonia - A prospective cohort study A. Jensen (Roskilde, Denmark)
Immunostimulating therapy in treatment of Community-acquired pneumonia F. Ahmedov (Samarkand, Uzbekistan)
Evaluation of thiol/disulfide redox status in community-acquired pneumonia E. Seref Parlak (Ankara, Turkey)
Feasibility of a quantitative polymerase chain reaction assay for diagnosing Streptococcus pneumoniae associated Community Acquired Pneumonia (CAP) N. Paternotte (Amsterdam , Netherlands)
Investigation of factors associated with result of pneumococcal urinary antigen in the microbiological investigation of pneumococcal lower respiratory infections F. Riviere (Clamart, France)
Cytokine-based prediction of aetiology in community acquired pneumonia R. Duijkers (Zaandam, Netherlands)
Cytokine responses, microbial etiology and short-term outcome in community-acquired pneumonia W. Siljan (Oslo, Norway)
Proadrenomedullin (proADM) for clinical severity and prognosis in patients with pneumonia O. Okutan (Istanbul, Turkey)
Role of thoracic ultrasound in the diagnosis of pneumonia E. Sobh (Al-Mahalla Al-Kobra, Egypt)
Do not resuscitat orders in community-acquired pneumonia: a restrospective cohort study. G. Baunbæk Egelund (FREDERIKSBERG, Denmark)
Late Breaking Abstract - Characterization of hospitalized patients with Influenza: a retrospective study M. Glória Galego (Matosinhos, Portugal)
Legionella pneumonia admissions in adults from 2000 to 2009 in mainland Portugal: A ten-year retrospective analysis A. Santos Dornellas Cysneiros (LISBOA, Portugal)